H.R. 3248
Referred to CommitteeDiagnostic Lab Testing Transparency Act
Latest Action
Referred to the Subcommittee on Health.
12/17/2024 • House
Summary
Diagnostic Lab Testing Transparency Act
This bill requires providers of clinical diagnostic laboratory tests under Medicare to publicly post certain information relating to the prices of services.
Specifically, providers must post and annually update information about the discounted cash price and the minimum and maximum negotiated rates of each test, including ancillary services. The Centers for Medicare & Medicaid Services may assess civil penalties for violations.
Introduced in House • 5/11/2023
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (2)
Party Breakdown
Sponsor
Cosponsors (1)
Bill Journey
Originated in the House
Introduced
May 11, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law